SCHEMBL1462289

SCHEMBL1462289

C=CC(=O)Nc1cccc(-c2cnc3ccccc3n2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 8/20 1.00
RAB9A P51151 5/20 0.71
NPC1 O15118 4/20 0.71
TP53 P04637 1/20 0.71
STAT1 P42224 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.71
KMT2A Q03164 7/20 0.68
MAPT P10636 4/20 0.67
ALDH1A1 P00352 2/20 0.67
HTT P42858 2/20 0.67
MITF O75030 1/20 0.67
LMNA P02545 1/20 0.67
JAK2 O60674 4/20 0.65
MEN1 O00255 6/20 0.63
CYP1A2 P05177 3/20 0.63
CYP3A4 P08684 3/20 0.63
CYP2C9 P11712 3/20 0.63
CYP2C19 P33261 2/20 0.63
NPSR1 Q6W5P4 1/20 0.63
TDP1 Q9NUW8 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1463376 0.86 RAB9A (0.76) JAK3RAB9ANPC1TP53STAT1
SCHEMBL24151517 0.85 JAK3 (0.74) JAK3RAB9ANPC1TP53STAT1
SCHEMBL30191150 0.85 JAK3 (0.74) JAK3RAB9ANPC1TP53STAT1
SCHEMBL15397453 0.84 JAK3 (0.73) JAK3RAB9ANPC1TP53STAT1
SCHEMBL16176755 0.84 JAK3 (0.73) JAK3RAB9ANPC1TP53STAT1
SCHEMBL1464227 0.84 JAK3 (0.73) JAK3RAB9ANPC1TP53STAT1
SCHEMBL24150637 0.84 JAK3 (0.72) JAK3RAB9ANPC1TP53STAT1
SCHEMBL30190706 0.84 JAK3 (0.72) JAK3RAB9ANPC1TP53STAT1
SCHEMBL18886118 0.82 JAK3 (0.70) JAK3RAB9ANPC1TP53STAT1
SCHEMBL18886117 0.82 JAK3 (0.69) JAK3RAB9ANPC1TP53STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8592415-B2 Selective kinase inhibitors REACTION BIOLOGY CORP. (US) 2013-11-26 US claimed
EP-2396004-A1 SELECTIVE KINASE INHIBITORS Reaction Biology Corp. (US) 2011-12-21 EP claimed
US-20110071149-A1 SELECTIVE KINASE INHIBITORS REACTION BIOLOGY CORP. (US) 2011-03-24 US claimed
WO-2010093808-A1 SELECTIVE KINASE INHIBITORS REACTION BIOLOGY CORP. (US) 2010-08-19 WO claimed
US-8592415-B2 Selective kinase inhibitors REACTION BIOLOGY CORP. (US) 2013-11-26 US disclosed
EP-2396004-A1 SELECTIVE KINASE INHIBITORS Reaction Biology Corp. (US) 2011-12-21 EP disclosed
US-20110071149-A1 SELECTIVE KINASE INHIBITORS REACTION BIOLOGY CORP. (US) 2011-03-24 US disclosed
US-20110071149-A1 SELECTIVE KINASE INHIBITORS REACTION BIOLOGY CORP. (US) 2011-03-24 US disclosed
US-20110071149-A1 SELECTIVE KINASE INHIBITORS REACTION BIOLOGY CORP. (US) 2011-03-24 US disclosed
WO-2010093808-A1 SELECTIVE KINASE INHIBITORS REACTION BIOLOGY CORP. (US) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071149-A1 SELECTIVE KINASE INHIBITORS JAK3, JAK1, JAK2 JAK3 1/4885RAB9A 1139/4885NPC1 3267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.